Vishesh D.

Inflection Point Ventures was started in 2018 with the aim of driving exponential value creation by being India’s most accessible & efficient network connecting a diverse investor community with a carefully set of curated startups. IPV is an early-stage angel investing platform, which provides both monetary and non-monetary support to the startups, as well as complete transparency around valuation, findings during due diligence, and personal interest (if any) to its investors. Today, it has 14,000+ angel investors, with the community having expanded beyond CXOs to include HNIs who come from varied backgrounds, professions and areas of expertise. IPV caters to investors pan India, and overseas, giving them access to startups and deals, making the group location and region agnostic. Since inception, we have invested in 250+ startups, with more in advanced stages of negotiations. IPV evaluation process screens startups and presents to investors only those, we feel have the potential to scale up. Till date we have considered startups spanning various industries such as Healthcare, Sports and Fitness, Retail Finance, HR, AI in hiring, Education, Supply Chain and Logistics etc, which shows that we do not have any predefined restrictions. For more information please visit our website.

Inflection Point Ventures was started in 2018 with the aim of driving exponential value creation by being India’s most accessible & efficient network connecting a diverse investor community with a carefully set of curated startups. IPV is an early-stage angel investing platform, which provides both monetary and non-monetary support to the startups, as well as complete transparency around valuation, findings during due diligence, and personal interest (if any) to its investors. Today, it has 14,000+ angel investors, with the community having expanded beyond CXOs to include HNIs who come from varied backgrounds, professions and areas of expertise. IPV caters to investors pan India, and overseas, giving them access to startups and deals, making the group location and region agnostic. Since inception, we have invested in 250+ startups, with more in advanced stages of negotiations. IPV evaluation process screens startups and presents to investors only those, we feel have the potential to scale up. Till date we have considered startups spanning various industries such as Healthcare, Sports and Fitness, Retail Finance, HR, AI in hiring, Education, Supply Chain and Logistics etc, which shows that we do not have any predefined restrictions. For more information please visit our website.

We offer a diverse range of cutting-edge software solutions tailored for modern businesses. Our sub-brands focus on delivering specialized products designed to enhance productivity, collaboration, and digital presence.

Seven Eidos is a mobile-internet company, driving innovation and excellence in B2B SaaS. Through our primary brand, 7tea1, we offer a diverse range of cutting-edge software solutions tailored for modern businesses. Our sub-brands focus on delivering specialized products designed to enhance productivity, collaboration, and digital presence. Additionally, under the brand Venturing with Vishesh, we provide expert advisory services and insightful podcasts, sharing invaluable knowledge and strategies with entrepreneurs and business leaders. At Seven Eidos, we are committed to fostering growth and creating impactful, tech-driven solutions that cater to a global audience.

Vamstar is the largest and fastest-growing AI-based global B2B healthcare supply chain platform. Using Machine Learning, Vamstar captures the demand for MedTech and Pharmaceutical products and services from 86000 buyers in 100+ countries and then matches this demand across the entire supplier base. Both buyers and suppliers across the industry use the platform to improve transaction and trading processes, capture real-time market insights (suppliers, products, and outcomes), launch better RFx and other sourcing programs, improve tender performance from the buyer-and-the-supplier side, and integrate ERP, CRM, and other downstream and upstream systems for full supply chain visibility. The platform connects pharmaceutical and medical device companies with public and private buyers, including corporates, clinics, hospitals, health insurance companies, and Group Purchasing Organisations (GPOs). Vamstar has sites in the United Kingdom, India, UAE, Netherlands, and the USA.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.